8STG | pdb_00008stg

Discovery and clinical validation of RLY-4008, the first highly selective FGFR2 inhibitor with activity across FGFR2 alterations and resistance mutations

CHAIN

A

CRISPR system single-strand-specific deoxyribonuclease Cas10/Csm1 (subtype III-A) - Thermococcus onnurineus NA1

Explore Sequence Annotations in 3D

LOADING

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.